Certara (NASDAQ:CERT) Shares Gap Down to $15.08

Certara, Inc. (NASDAQ:CERT) shares gapped down before the market opened on Wednesday . The stock had previously closed at $15.08, but opened at $13.49. Certara shares last traded at $13.04, with a volume of 77,973 shares changing hands.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on the company. KeyCorp decreased their price target on Certara from $23.00 to $20.00 and set an “overweight” rating on the stock in a research report on Thursday, July 11th. JMP Securities reiterated a “market perform” rating on shares of Certara in a research report on Wednesday, July 10th. Finally, Barclays decreased their price objective on shares of Certara from $18.00 to $16.00 and set an “equal weight” rating on the stock in a research report on Friday, June 28th. Seven investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $19.44.

Certara Trading Down 9.4 %

The company has a current ratio of 3.26, a quick ratio of 3.26 and a debt-to-equity ratio of 0.27. The stock has a 50 day simple moving average of $15.16 and a 200-day simple moving average of $16.55. The firm has a market cap of $2.20 billion, a P/E ratio of -33.44, a P/E/G ratio of 5.39 and a beta of 1.52.

Certara (NASDAQ:CERT) last posted its quarterly earnings data on Tuesday, May 7th. The company reported $0.06 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.01). Certara had a negative net margin of 17.02% and a positive return on equity of 4.08%. The business had revenue of $96.65 million for the quarter, compared to analysts’ expectations of $94.48 million. On average, equities research analysts expect that Certara, Inc. will post 0.28 EPS for the current fiscal year.

Hedge Funds Weigh In On Certara

A number of large investors have recently bought and sold shares of the business. Mubadala Investment Co PJSC purchased a new stake in shares of Certara in the 4th quarter worth $169,135,000. Franklin Resources Inc. boosted its stake in shares of Certara by 8.2% in the fourth quarter. Franklin Resources Inc. now owns 1,820,864 shares of the company’s stock worth $32,029,000 after buying an additional 138,682 shares during the last quarter. Sei Investments Co. boosted its position in Certara by 12.4% during the first quarter. Sei Investments Co. now owns 715,514 shares of the company’s stock worth $12,793,000 after purchasing an additional 79,013 shares in the last quarter. Edmond DE Rothschild Holding S.A. raised its holdings in shares of Certara by 93.1% during the fourth quarter. Edmond DE Rothschild Holding S.A. now owns 769,300 shares of the company’s stock valued at $13,532,000 after acquiring an additional 370,820 shares during the last quarter. Finally, Norges Bank acquired a new stake in shares of Certara in the fourth quarter valued at approximately $14,262,000. Hedge funds and other institutional investors own 73.96% of the company’s stock.

About Certara

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.